Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros®
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros®
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2026
2025
2024
2023
2022
2026
2026-05-26 16:40
Prolight Diagnostics publishes quarterly report Q1, 2026
Regulatory
MAR
2026-05-26 16:30
Annual general meeting of Prolight Diagnostics AB (publ) on 26 May 2026
Regulatory
2026-05-05 15:30
Prolight Diagnostics AB (publ) publishes annual report for 2025
Regulatory
2026-04-29 08:00
Prolight Diagnostics achieves design freeze for Psyros® instrument
2026-04-28 08:00
Prolight secures second patent in Japan for Psyros® technology
2026-04-21 17:10
NOTICE OF THE ANNUAL GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
Regulatory
2026-04-14 16:32
Prolight selected as semi-finalist for ADLM 2026 Disruptive Technology Award Competition
2026-03-24 08:15
Prolight Diagnostics publishes investorletter for March 2026
2026-03-24 08:00
Prolight reports positive Traumatic Brain Injury (TBI) biomarker results with BRAINBox Solutions, confirming broad assay potential of the Psyros™ POC platform
2026-03-09 08:00
Prolight Diagnostics’ POC system Psyros attracted significant attention at the recently concluded international WHX Labs congress
Next
